Ticker: TVTX

Company Overview: Travere Therapeutics, Inc. (NASDAQ: TVTX) is a biopharmaceutical company focused on developing therapies for rare kidney and metabolic diseases. The company has been expanding its product pipeline and recently achieved critical milestones with its products. Key Financial Highlig...

Travere Therapeutics, Inc. (NASDAQ: TVTX) has reported significant developments in its financial position and product offerings for the first quarter of 2025. Here’s a concise breakdown of key metrics and insights into the company's operations. Key Financial Highlights: Net product sales: $75.9 ...